Skip to content

Comparison of Emergence Quality Following Different Sedation Regimens for Magnetic Resonance Imaging in Infants: A Prospective Randomized Controlled Study

Comparison of Emergence Quality Following Different Sedation Regimens for Magnetic Resonance Imaging in Infants: A Prospective Randomized Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124590
Enrollment
Unknown
Registered
2026-05-14
Start date
2026-05-15
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric patients requiring sedation for magnetic resonance imaging

Interventions

Dexmedetomidine combined with chloral hydrate group (DC group):Forty to fifty minutes prior to the examination, under parental, the child received intranasal dexmedetomidine at a dose of 2 µg/kg and o
Dexmedetomidine combined with midazolam group (DM group):Forty to fifty minutes prior to the examination, the child was calmed by parents and administered 2 µg/kg dexmedetomidine via nasal drops and 0
Dexmedetomidine combined with esketamine group (DE group):Forty to fifty minutes prior to the procedure, the child received intranasal dexmedetomidine at a dose of 2 µg/kg from the same experienced se

Sponsors

Children's Hospital Zhejiang university school of medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: 1. Children undergoing MRI examination at our hospital, with an anticipated scan duration of 10–45 minutes; 2. Age: 1 month (corrected age for preterm infants >1 month) to 1 year, ASA physical status classification II–III; 3. No history of severe upper airway obstruction; 4. Written informed consent obtained from the child’s parent or legal guardian.

Exclusion criteria

Exclusion criteria: 1. Severe obesity (BMI > 3 standard deviations above the age-specific reference value); 2. History of allergy to sedative medications; 3. Severe systemic diseases: heart failure, hepatic or renal insufficiency; 4. Difficult airway, severe obstructive sleep apnea; 5. Fever (>=38.5°C), purulent sputum, pneumonia; 6. Nasal mucosal injury or gastrointestinal obstruction/reflux; 7. History of arrhythmia, particularly chronic arrhythmia.

Design outcomes

Primary

MeasureTime frame
Rate of delayed awakening;sedation success rate;Overall success rate of sedation;induction time;Parental satisfaction;respiratory depression;

Countries

China

Contacts

Public ContactZhou Xiaqing

Children's Hospital Zhejiang university school of medicine

243391079@qq.com+86 150 6875 4798

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026